Raymond James Financial Services Advisors’s Blueprint Medicines BPMC Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $3.48M | Buy |
37,668
+4,671
| +14% | +$432K | ﹤0.01% | 1427 |
|
2024
Q2 | $3.56M | Sell |
32,997
-3,932
| -11% | -$424K | 0.01% | 1344 |
|
2024
Q1 | $3.5M | Buy |
36,929
+2,884
| +8% | +$274K | 0.01% | 1336 |
|
2023
Q4 | $3.14M | Sell |
34,045
-8,664
| -20% | -$799K | 0.01% | 1326 |
|
2023
Q3 | $2.14M | Sell |
42,709
-18,938
| -31% | -$951K | ﹤0.01% | 1467 |
|
2023
Q2 | $3.9M | Buy |
61,647
+26,292
| +74% | +$1.66M | 0.01% | 1155 |
|
2023
Q1 | $1.59M | Sell |
35,355
-298
| -0.8% | -$13.4K | ﹤0.01% | 1624 |
|
2022
Q4 | $1.56M | Sell |
35,653
-8,533
| -19% | -$374K | ﹤0.01% | 1584 |
|
2022
Q3 | $2.91M | Buy |
44,186
+3,211
| +8% | +$212K | 0.01% | 1219 |
|
2022
Q2 | $2.07M | Buy |
40,975
+7,601
| +23% | +$384K | ﹤0.01% | 1420 |
|
2022
Q1 | $2.13M | Sell |
33,374
-263
| -0.8% | -$16.8K | ﹤0.01% | 1449 |
|
2021
Q4 | $3.6M | Buy |
33,637
+5,969
| +22% | +$639K | 0.01% | 1184 |
|
2021
Q3 | $2.85M | Buy |
27,668
+7,281
| +36% | +$749K | 0.01% | 1280 |
|
2021
Q2 | $1.79M | Buy |
20,387
+525
| +3% | +$46.2K | ﹤0.01% | 1537 |
|
2021
Q1 | $1.93M | Sell |
19,862
-6,787
| -25% | -$660K | ﹤0.01% | 1424 |
|
2020
Q4 | $2.99M | Sell |
26,649
-7,925
| -23% | -$889K | 0.01% | 1071 |
|
2020
Q3 | $3.21M | Sell |
34,574
-3,884
| -10% | -$360K | 0.01% | 948 |
|
2020
Q2 | $3M | Sell |
38,458
-1,486
| -4% | -$116K | 0.01% | 935 |
|
2020
Q1 | $2.34M | Buy |
39,944
+19,120
| +92% | +$1.12M | 0.01% | 822 |
|
2019
Q4 | $1.67M | Buy |
20,824
+18,046
| +650% | +$1.45M | 0.01% | 1250 |
|
2019
Q3 | $204K | Sell |
2,778
-403
| -13% | -$29.6K | ﹤0.01% | 2492 |
|
2019
Q2 | $300K | Buy |
+3,181
| New | +$300K | ﹤0.01% | 2274 |
|
2017
Q3 | – | Sell |
-10,360
| Closed | -$525K | – | 2526 |
|
2017
Q2 | $525K | Buy |
+10,360
| New | +$525K | ﹤0.01% | 1647 |
|